Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma

• Published in: Biomedical Research Vol. 40; no. 1; pp. 17 - 27
• Main Authors: HAGIUDA, Daisuke, NAGASHIO, Ryo, ICHINOE, Masaaki, TSUCHIYA, Benio, IGAWA, Satoshi, NAOKI, Katsuhiko, SATOH, Yukitoshi, MURAKUMO, Yoshiki, SAEGUSA, Makoto, SATO, Yuichi
• Format: Journal Article
• Language: English
• Published: Japan Biomedical Research Press 01-02-2019; Japan Science and Technology Agency
• Subjects: Adenocarcinoma; Cell migration; Diagnostic systems; Localization; Lung cancer; Medical prognosis; Metastases; Prognosis; siRNA; UDP-glucose 6-dehydrogenase
• ISSN: 0388-6107; 1880-313X
• DOI: 10.2220/biomedres.40.17

This study aimed to clarify relationships among UDP-glucose-6 dehydrogenase (UGDH) expression, clinicopathological factors, and the prognosis of patients, and to determine the role of UGDH in lung adenocarcinoma (AC). Firstly, UGDH expression and localization in 126 lung AC tissues were immunohistochemically studied, and associations with clinicopathological parameters and patients’ prognosis were evaluated. Secondly, serum UGDH levels were measured in 267 lung cancer patients and 100 healthy controls. Finally, the effects of UGDH knockdown by siRNA on migration and invasion abilities were analyzed. As a result, nuclear UGDH staining was significantly correlated with poorer differentiation, a larger tumor size, higher p-TNM stage, positive nodal metastasis, positive lymphatic invasion, and positive vascular invasion in lung AC patients. Nuclear UGDH-positive patients showed significantly poorer survival than nuclear UGDH-negative patients. Serum UGDH levels were especially higher in lung AC patients even in stage I than those in healthy controls. In lung AC cell lines, nuclear expression levels of UGDH were higher in LC-2/ad cells than in A549 cells. UGDH siRNA-treated LC-2/ad cells showed significantly decreased migration and invasion abilities, but no significant differences were observed in UGDH siRNA-treated A549 cells. These data indicate that UGDH expression and localization are an early sero-diagnostic marker in addition to a poor prognostic indicator in lung AC patients.